Clover Corp Ltd (ASX: CLV) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Clover Corporation Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $242.81 million
P/E Ratio 23.70
Dividend Yield 2.05%
Shares Outstanding 166.31 million
Earnings per share 0.062
Dividend per share 0.03
Year To Date Return -12.01%
Earnings Yield 4.22%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Clover Corp Ltd (ASX: CLV)
Latest News

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
07 Apr 2021 $0.0050 100.00% Interim 29 Apr 2021
27 Oct 2020 $0.0250 100.00% Final 18 Nov 2020
29 Oct 2019 $0.0175 100.00% Final 20 Nov 2019
08 Apr 2019 $0.0063 100.00% Interim 30 Apr 2019
29 Oct 2018 $0.0125 100.00% Final 20 Nov 2018
09 Apr 2018 $0.0050 100.00% Interim 01 May 2018
27 Oct 2017 $0.0075 100.00% Final 20 Nov 2017
10 Apr 2017 $0.0025 100.00% Interim 01 May 2017
27 Oct 2016 $0.0050 100.00% Final 21 Nov 2016
11 Apr 2016 $0.0025 100.00% Interim 02 May 2016
28 Oct 2015 $0.0050 100.00% 20 Nov 2015
29 Oct 2014 $0.0050 100.00% 20 Nov 2014
29 Nov 2010 $0.0125 100.00% Final 15 Dec 2010
16 Nov 2004 $0.0100 38.00% 30 Nov 2004

CLV ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Clover Corp Ltd

Clover Corp Ltd provides nutritional and functional ingredients. The company is involved in the production of encapsulated powders, and research and product development of functional food and infant nutrition ingredients. It offers Nu-MegaHi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; and Ocean Gold refined tuna oils. Its products include DHA oils, DHA powders, and Microencapsulation. Geographically, the group has a business presence in Australia, New Zealand, Asia, Europe, and the Americas, of which key revenue is derived from Australia, New Zealand, and Asia.

CLV Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
17 Sep 2021 $1.46 $0.06 4.29% 114,457 $1.45 $1.46 $1.42
16 Sep 2021 $1.40 $-0.06 -4.11% 132,057 $1.42 $1.46 $1.40
15 Sep 2021 $1.46 $0.00 0.00% 203,662 $1.45 $1.47 $1.40
14 Sep 2021 $1.46 $-0.04 -2.67% 134,132 $1.48 $1.50 $1.46
13 Sep 2021 $1.50 $-0.02 -1.32% 97,843 $1.53 $1.55 $1.47
10 Sep 2021 $1.52 $0.00 0.00% 609,601 $1.55 $1.56 $1.52
09 Sep 2021 $1.52 $-0.05 -3.17% 32,543 $1.57 $1.57 $1.52
08 Sep 2021 $1.58 $0.03 1.95% 48,970 $1.52 $1.58 $1.52
07 Sep 2021 $1.54 $-0.01 -0.65% 53,076 $1.55 $1.56 $1.54
06 Sep 2021 $1.55 $-0.02 -1.27% 119,528 $1.57 $1.57 $1.50
03 Sep 2021 $1.58 $-0.05 -3.09% 152,386 $1.59 $1.61 $1.56
02 Sep 2021 $1.62 $0.02 1.25% 83,837 $1.60 $1.62 $1.58
01 Sep 2021 $1.60 $-0.01 -0.62% 103,553 $1.62 $1.63 $1.59
31 Aug 2021 $1.61 $0.01 0.63% 27,195 $1.60 $1.63 $1.60
30 Aug 2021 $1.60 $-0.04 -2.44% 72,452 $1.64 $1.64 $1.60
27 Aug 2021 $1.64 $0.00 0.00% 71,607 $1.64 $1.65 $1.60
26 Aug 2021 $1.64 $0.02 1.23% 75,970 $1.64 $1.64 $1.61
25 Aug 2021 $1.62 $0.05 3.17% 96,862 $1.58 $1.65 $1.58
24 Aug 2021 $1.58 $-0.03 -1.87% 79,370 $1.62 $1.62 $1.56
23 Aug 2021 $1.61 $-0.07 -4.19% 51,022 $1.64 $1.65 $1.61
20 Aug 2021 $1.67 $0.00 0.00% 59,890 $1.69 $1.69 $1.62

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
09 Dec 2020 Peter Davey Sell 227 $404,024
On-market trade.
01 Dec 2020 Peter Davey Buy 470 $838,061
Conversion of securities.
01 Dec 2020 Peter Davey Exercise 470 $838,061
Conversion of securities. 240,174 - performance rights
29 Oct 2020 Simon Green Buy 11 $20,901
On-market trade.
22 Oct 2020 Rupert Harrington Buy 57 $99,485
On-market trade.
21 Oct 2020 Toni Brendish Buy 17 $30,107
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Ian David Glasson Non-Executive Director Feb 2017
Mr Glasson is former CEO of PGG Wrightson based in Christchurch, New Zealand. He was formerly CEO of Gold Coin Group / Zuellig Agriculture which managed a portfolio of animal feed operations and farming ventures throughout South East Asia. Prior to that he was CEO for seven years of Sucrogen (formerly the sugar business of listed entity CSR and now owned by Wilmar). He has also had agribusiness experience with Goodman Fielder and Gresham Rabo, as well as spending the first sixteen years of his career in the oil and gas sector with Esso.
Ms Toni Brendish Non-Executive Director Oct 2020
Ms Brendish has more than 30 years' experience, including over 20 years in CEO or Managing Director roles, mainly working for blue chip fast-moving consumer goods, services and telecommunication companies. She has experience in manufacturing, supply chain and regulatory management of infant formula markets across Asia, Australia, New Zealand, China and Europe.
Mr Rupert Anthony Harrington Non-Executive DirectorNon-Executive Chairman Jul 2015
Mr Harrington is an experienced Director with experience in business strategy and M & A. Mr Harrington's earlier career was in operational management in the UK and Australia. His career since 1987 has been in Private Equity where he has record of delivering results for investors in sectors including: health, technology, industrial services and manufacturing. He is currently non-executive Chairman of Advent Partners. At the end of 2017 he resigned as a Non-Executive Director of Bradken Limited following its acquisition by Hitachi.
Mr Graeme Ambery Billings Non-Executive Director May 2013
Mr Billings was a partner at Coopers and Lybrand and then PricewaterhouseCoopers (PwC) for 24 years. Mr Billings was head of PwC's Melbourne Assurance practice for a number of years as well as Global Leader of PwC's Industrial Products and Manufacturing industry group. Mr Billings brings a range of financial, corporate governance, internal control, commercial and corporate transactional skills to the Company.
Mr Peter J Davey Chief Executive OfficerManaging Director Dec 2014
Mr Davey has a record of building businesses across a range of industry sectors. He has held senior management positions within a number of manufacturing and distribution companies operating in competitive and markets. Mr Davey has interest in sales and marketing, and development and implementation of strategies for growth. Mr Davey was formerly Executive Manager AgriProducts and a director of Viterra Australia Limited, responsible for the AgriProducts division. In earlier roles, Mr Davey headed the Sales and Marketing divisions of FMP Products and Hi Fert Pty Ltd. During his career, Mr Davey has had a focus on marketing based businesses operating in the Asia and Oceania regions.
Dr Simon Green Non-Executive Director Oct 2020
Dr Green has 30 years of experience in the biotechnology industry focused on the discovery, development and commercialisation of life saving medicines. He was involved in CSL's global expansion and held roles as Senior Vice President in R&D and manufacturing operations.
Mr Andrew Allibon Chief Financial OfficerCompany Secretary May 2021
-
Andrew Allibon Chief Financial OfficerCompany Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Washington H Soul Pattinson & Co Ltd 33,423,035 20.10%
J P Morgan Nominees Australia Ltd 12,411,640 7.46%
UBS Nominees Ltd 10,434,600 6.27%
Citicorp Nominees Pty Ltd 9,446,012 5.67%
National Nominees Ltd 8,540,202 5.14%
Evelin Investments Pty Ltd 7,550,000 4.54%
BNP Paribas Noms Pty Ltd 6,185,330 3.72%
Neweconomy Com Au Nominees Pty Ltd 4,254,599 2.56%
BNP Paribas Nominees Pty Ltd 2,553,982 1.54%
Neweconomy Com Au Nominess Pty Ltd 2,129,570 1.28%
Incani & Papadoppoulos Super Pty Ltd 2,010,000 1.21%
BNP Paribas Nominees Pty Ltd (I) 2,000,769 1.20%
Mr Peter Howells 1,500,000 0.90%
Custodial Services Ltd 1,078,419 0.65%
Mr Garrie Ellice 1,020,000 0.61%
CS Third Nom Pty Ltd 947,104 0.57%
Mr Pei Yin Foo 900,000 0.54%
Ms Nina Tschernykow 858,881 0.52%
Connaught Consultants (Finance) Pty Ltd 821,400 0.49%
Ganesh Super Fund 774,696 0.47%

Profile

since

Note